*Yoichiro Fujioka1,2, Fumiya Kozawa1, Taro Ichimura3, Taishi Kakizuka4, Rumi Shimada1, Yasuyuki Hashimoto1, Sayaka Kashiwagi1,2, Tomoko Kamasaki1,2, Maho Amano1, Takeharu Nagai3,4, Yusuke Ohba1,2 (1. Dep. of Cell Physiol., Fac of Med. and Grad. Sch. of Med., Hokkaido Univ., 2. AMED-CREST, 3. OTRI, Osaka Univ., 4. SANKEN, Osaka Univ.)
Session information
Oral Presentation
[1O-Ca] Oral Session 3
Wed. Jul 17, 2024 1:15 PM - 3:45 PM Venue C (2F Conference Room 201)
Chairs:Tetsuya Kobayashi(The University of Tokyo), Kazuhiro Aoki(NIBB/Kyoto University)
Time Adjustment
*Toshimasa Uemura1,2, Mari Shimura3,4, Satoshi Matsuyama3,5, Masao Sasai6, Yuto Tanaka7, Junya Yoshimizu5, Kazuto Yamauchi1,2, Shigeru Miyagawa6 (1. Osaka University, Osaka University-RIKEN Center for Science and Technology, 2. JTEC CORPORATION, 3. RIKEN, 4. National Center for Global Health and Medicine, Research Institute, 5. Nagoya University, Department of Materials Physics, 6. Osaka University, Graduate School of Medicine, 7. Osaka University, Graduate School of Technology)
*Daisuke Nanba1, Jun-Ichi Sakabe2, Johannes Mosig3, Michel Brouard3, Yann Barrandon2,3 (1. Tottori Univ. Faculty of Medicine, 2. Singapore General Hospital, 3. EPFL)
*Akihito Inoko1,2, Norihito Soga2, Minako Suzuki1, Tohru Kiyono3, Junichi Ikenouchi4, Yoshikatsu Sato5, Daisuke Saito4, Tatsuo Miyamoto6, Naoki Goshima7, Yuko Hayashi2, Hideaki Ito1, Kenji Kasai1 (1. Div. Path., Aichi Med. Univ., Sch. Med., 2. Aichi Cancer Ctr., 3. Ntl. Cancer Ctr., 4. Kyushu Univ., 5. Nagoya Univ., 6. Yamaguchi Univ., 7. AIST)
*Ami Sugisawa1, Shiori Ueda2, Yuika Okuda3, Ryo Ushioda1,3,4 (1. Kyoto Sangyo Univ. Division of Life Science, 2. Kyoto Univ. Division of Life Science, 3. Kyoto Sangyo Univ. Life Science Department, 4. Protein. Dynamics. Lab., Kyoto Sangyo Univ.)
[1C13] Mechanism of protein quality maintenance via ER stress-dependent co-translational degradation
*Hisae Kadowaki1, Hideki Nishitoh1 (1. Laboratory of Biochemistry and Molecular Biology Department of Medical Sciences University of Miyazaki)
*Daiki Kitamura1, Kiichiro Taniguchi1, Mai Nakamura1, Tatsushi Igaki1 (1. Graduate School of Biostudies, Kyoto University)
*Zhenzhou Fang1, Xingming Li1, Yuki Yoshino1, Natsuko Chiba1 (1. Tohoku University, Department of Cancer Biology, IDAC )
*Eriko Deguchi1, Shuhao Lin2, Kimiya Matsuda2, Daiki Hirayama2, Shinya Tsukiji3, Michiyuki Matsuda2, Kenta Terai4 (1. Department of Molecular Oncology, Graduate School of Medicine, Kyoto University, 2. Department of State-of-the-art and International Medicine, Graduate School of Medicine, Kyoto University, 3. Department of Nanopharmaceutical Sciences, Graduate School of Engineering, Nagoya Institute of Technology, 4. Department of Histology, Graduate School of Biomedical Sciences, Tokushima University)
*Tatsuki Tsuruoka1,2,3,4, Yuhei Goto1,2,3,4, Kazuhiro Aoki1,2,3,4 (1. Kyoto University, Graduate School of Biostudies Division of Integrated Life Science, Department of Gene Mechanisms, Laboratory of Cell Cycle Regulation, 2. Quantitative Biology Research Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, 3. Division of Quantitative Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, 4. Department of Basic Biology, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies))
*Shuhei Kuwabara1, Hiro Inoue1, William T. Nash1, Junlan Yao1, Shuqiu Zheng1, Mark D. Okusa1 (1. Div. of Nephrology, Sch. of Medicine, Univ. of Virginia)
*Toru Hiratsuka1, Shoko Tsukamoto2, Houssam Alkoussa2, Akihito Machinaga3, Nobuyuki Kakiuchi4, Seishi Ogawa5,6,7, Hiroshi Seno7,4, Shigeki Higashiyama1, Michiyuki Matsuda2 (1. Oncogenesis and Growth Regulation, Research Center, Osaka International Cancer Institute, 2. Laboratory of Cell Cycle Regulation, Graduate School of Biostudies, Kyoto University, 3. Oncology Tsukuba Research Department, Discovery, Medicine Creation, OBG, Eisai Co., Ltd, 4. Department of Gastroenterology and Hepatology, Kyoto University, 5. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, 6. Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, 7. Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Sweden)
*Bungo Kakemura1, Dan Liu2,3, Christos Samakovlis4, Tatsushi Igaki1 (1. Laboratory of Genetics, Graduate School of Biostudies, Kyoto University, 2. Centre for Cancer Cell Reprogramming, Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 3. Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 4. Science for Life Laboratory, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University)